Fundraising Fox
/Companies
Sign in

Pionyr Immunotherapeutics

San Francisco, US · Founded 2015 · Delaware corporation · 53 employees on LinkedIn · 7 known investors

Find your way into Pionyr Immunotherapeutics

Sign up to see every warm intro you have to Pionyr Immunotherapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pionyr Immunotherapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Healthtech

Founders & leadership

Pionyr Immunotherapeutics was founded in 2015 by Matthew F. Krummel, Ph.D..

MF
Matthew F. Krummel, Ph.D.Founder
SPSteven P. James
Steven P. JamesPresident & CEO2016–2023Steven P. James has spent over 35 years in pharmaceutical and biotechnology leadership, serving as CEO of Labrys Biologics, KAI Pharmaceuticals, and Pionyr Immunotherapeutics. He holds or has held board positions at multiple biotech companies including Allakos, Ventus Therapeutics, and Lyterian Therapeutics.
LC
Leon Chen, Ph.D.Named on SEC filing
CGCarol Gallagher
Carol GallagherNamed on SEC filingAdvisor at New Enterprise Associates (NEA)
JR
Joshua Resnick, M.D.Named on SEC filing

Board

MP
Michael PowellBoard directorGeneral Partner at Sofinnova Venture Partners

Investors · 7

Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K

How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us

Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M

How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

OrbiMedreportedNew York · $1M – $75M

How we know: a partner's Signal profile · Not right? Tell us

Sofinnova Venture PartnersinferredMenlo Park

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$45M disclosed across 2 rounds · 2017–2018

▶$7MraisedApr 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Carol GallagherDirector
  • Joshua Resnick, M.D.Director
  • Matthew F. Krummel, Ph.D.Director
  • Leon Chen, Ph.D.Director
  • Steven P. JamesExecutive Officer, Director, Promoter
  • Michael PowellDirector
Offering amount
$7M
Amount sold
$7M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Leon Chen, Ph.D.Director
  • Matthew F. Krummel, Ph.D.Director
  • Michael PowellDirector
  • Carol GallagherDirector
  • Joshua Resnick, M.D.Director
  • Steven P. JamesExecutive Officer, Director, Promoter
Offering amount
$62M
Amount sold
$38M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Pionyr Immunotherapeutics went on to found or lead other companies.

Arjun GoyalMember Board Of DirectorsFounded Affini-T TherapeuticsCarol GallagherDirectorFounded Calistoga PharmaceuticalsBill GrossmanMember Board Of DirectorsFounded Oncko

Frequently asked questions

Who founded Pionyr Immunotherapeutics?
Pionyr Immunotherapeutics was founded by Matthew F. Krummel, Ph.D. in 2015.
Who are Pionyr Immunotherapeutics's investors?
Pionyr Immunotherapeutics's investors include Mission Bay Capital, Mission Biocapital, New Enterprise Associates (NEA), OUP (Osage University Partners), Sofinnova Ventures, OrbiMed, Sofinnova Venture Partners.
How much funding has Pionyr Immunotherapeutics raised?
Pionyr Immunotherapeutics has disclosed $45M raised across 2 rounds.
Where is Pionyr Immunotherapeutics headquartered?
Pionyr Immunotherapeutics is headquartered in San Francisco, US.